2-Piperidone → HCID 71252107, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH2:4][CH2:3][C:2]1=[O:7].Br[C:9]1[CH:14]=[CH:13][C:12]([C:15]([N:17]2[CH2:22][CH2:21][N:20]([C:23]3[CH:28]=[CH:27][C:26]([CH3:29])=[CH:25][C:24]=3[CH3:30])[CH2:19][CH2:18]2)=[O:16])=[C:11]([S:31]([CH3:34])(=[O:33])=[O:32])[CH:10]=1>>[CH3:30][C:24]1[CH:25]=[C:26]([CH3:29])[CH:27]=[CH:28][C:23]=1[N:20]1[CH2:19][CH2:18][N:17]([C:15]([C:12]2[CH:13]=[CH:14][C:9]([N:1]3[CH2:6][CH2:5][CH2:4][CH2:3][C:2]3=[O:7])=[CH:10][C:11]=2[S:31]([CH3:34])(=[O:33])=[O:32])=[O:16])[CH2:22][CH2:21]1Participants
3
Procedure
Using piperidin-2-one (104 mg) and (4-bromo-2-methanesulfonylphenyl)[4-(2,4-dimethylphenyl)piperazin-1-yl]methanone (451 mg) described in Preparation Example 110 and by the reaction and treatment in the same manner as in Example 1, the title compound (293 mg) was obtained.
Workup
- customdescribed in Preparation Example 110 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-a77223a7a7af4f63a889c2e71bf0874a
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…